Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +62.71%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.49%
#5 Velvet Velvet +46.29%
#6 Cross Cross +37.03%
#7 Black Phoenix Black Phoenix +34.20%
#8 Cap Cap +20.04%
#9 DoubleZero DoubleZero +15.02%
#10 Humanity Humanity +11.35%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Ganga Pharmaceuticals Limited Ganga Pharmaceuticals Limited

Ganga Pharmaceuticals Limited

GANGAPHARM
Classificação em ações #39130
Ganga Pharmaceuticals Ltd. is actively involved in the production and trade of... Ganga Pharmaceuticals Ltd. is actively involved in the production and trade of pharmaceutical products and related goods. The company primarily concentrates on the formulation, marketing, and supply of Ayurvedic medicines in bulk quantities. Notable products in its portfolio include Ampachan Vati, Khadira Vati, and Nirmalaya Churna. The firm offers a range of Ayurvedic solutions designed to address health issues such as acidity, dandruff, oxidative stress, constipation, oral hygiene, diarrhea, ear ailments, women's health, and joint discomfort. Brijmohan C. Sharma founded the organization in 1974, and its main corporate office is located in Mumbai, India.
Preço da ação
$0.13243053
Última sincronização: 2026-03-16
Valor de mercado
$637.36K
Variação (1 dia)
0.00%
Variação (1 ano)
-20.46%
País
IN
Negociar Ganga Pharmaceuticals Limited (GANGAPHARM)

Categoria

Healthcare
Lucros da Ganga Pharmaceuticals Limited (GANGAPHARM)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Ganga Pharmaceuticals Limited, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Ganga Pharmaceuticals Limited de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US